Establishing sepsis diagnostic InfectID™as the new standard of care
BRISBANE,Australia,Dec. 5,2024-- Microbio Ltd,the Australian pathogen diagnostics companyspecialising in innovative molecular diagn
Combining Sustainable Luxury and Cutting-Edge Design in Japan\'s Capital
MIAMI,Dec. 5,2024-- SH Hotels & Resorts,the sustainable hotel brand management company founded by hospitality visionary B
BEIJING,Dec. 2,2024--Leaders from multiple countries are scheduled to visit China on Monday,including Nepal\'s Prime Minister KP SharmaOli,Cambodian People\'s Party (CPP) President and Senate Presiden
FOSHAN,China,Dec. 2,2024-- On November 15,2024,China\'s Ministry of Finance announced changes to the export tax rebate policy,affecting industries including aluminum manufacturing.Syharvest Aluminum,a
SAN JOSE,Calif.,Dec. 2,2024-- Balbix,the leader in cyber risk and exposure management,announced today three new generative artificial intelligence (AI) products in AWS Marketplace,a digital catalog w
SHANGHAI,Dec. 2,2024-- Eshallgo Inc ("Eshallgo" or the "Company") (NasdaqCM: EHGO),one of the leading office solution providers in China,today announced that it has entered into a
INCHEON,South Korea,Dec. 3,2024-- Samsung Biologics (KRX: 207940.KS),a global contract development and manufacturing organization (CDMO),today hosted its second Supplier ESG Day to share insights on
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).